Results 181 to 190 of about 73,071 (237)

Results of a phase II open-label, multiple-dose study of vamorolone (VBP15-006) in 7- to < 18-year-old boys with duchenne muscular dystrophy. [PDF]

J Neurol
Lochmüller H, Gonorazky H, Nigro E, Mah JK, Alemán A, Yaworski A, Oskoui M, Sbrocchi AM, Selby K, de Vera A, McAdam L, Gresko E, Linden A, Dutreix C, Hoffman EP.   +14 more
europepmc   +1 more source

Assessing the Relationship of Quality of Life With Functional Status in a Large Cohort of Adult Patients With Neuromuscular Disorders. [PDF]

Neurol Clin Pract
Wong KSW, Sen A, Michell-Sodhi J, Moat D, McCallum M, Richardson M, Harris E, Mayhew AG, Guglieri M, Grover E, Diaz-Manera J, Robinson E, Elseed M, Mason J, Geagan C, James MK, Straub V, Marini-Bettolo C, Muni-Lofra R.   +18 more
europepmc   +1 more source

Management of adrenal insufficiency risk after long-term systemic glucocorticoid therapy in Duchenne muscular dystrophy: Clinical practice recommendations [PDF]

, 2019
Bowden, Sasigarn A, Connolly, Anne M, Kinnett, Kathi, Zeitler, Philip S   +3 more
core   +1 more source

Burden of Duchenne muscular dystrophy in Australia: a scoping review. [PDF]

BMJ Neurol Open
Lee E, Choi S, Kim H.
europepmc   +1 more source

Caregiver burden in Duchenne muscular dystrophy in Europe, Japan, and the United States - a real-world study. [PDF]

BMC Neurol
Strober J, Ishigaki K, Posner N, Cappelleri JC, Xiao S, Talaga A, Dukacz S, Iqbal H, Chatterton E, Morton E, Weatherby S, de Courcy J.   +11 more
europepmc   +1 more source

Rethinking Corticosteroid Therapy in Pediatric Neurology. [PDF]

J Inflamm Res
Lin WS.
europepmc   +1 more source

Acute Gastric Dilatation in a 16-Year-Old Patient With Duchenne Muscular Dystrophy: A Case Report and an Updated Literature Review. [PDF]

Cureus
Novoa Garnica C, Ruíz Hernandez CJ, Montells S, Arias MH, Martin Carpi FJ.   +4 more
europepmc   +1 more source